A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer

H Shi, J Guo, C Li, Z Wang - Drug design, development and …, 2015 - Taylor & Francis
Lung cancer remains the leading common cause of cancer-related death, with non-small-
cell lung cancer (NSCLC) accounting for 80% of all cases. To date, platinum-based doublet …
被引用次数：115 相关文章

A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer

H Shi, J Guo, C Li, Z Wang - Drug Design, Development and …, 2015 - search.proquest.com
Lung cancer remains the leading common cause of cancer-related death, with non-small-
cell lung cancer (NSCLC) accounting for 80% of all cases. To date, platinum-based doublet …
[PDF] core.ac.uk

[PDF][PDF] A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer

H Shi - Drug Design, Development and Therapy, 2015 - core.ac.uk
Lung cancer remains the leading common cause of cancer-related death, with non-small-
cell lung cancer (NSCLC) accounting for 80% of all cases. To date, platinum-based doublet …
[PDF] semanticscholar.org

[PDF][PDF] A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer

H Shi - Drug Design, Development and Therapy, 2015 - pdfs.semanticscholar.org
Lung cancer remains the leading common cause of cancer-related death, with non-small-
cell lung cancer (NSCLC) accounting for 80% of all cases. To date, platinum-based doublet …
[PDF] scienceopen.com

[PDF][PDF] A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer

H Shi - Drug Design, Development and Therapy, 2015 - scienceopen.com
Lung cancer remains the leading common cause of cancer-related death, with non-small-
cell lung cancer (NSCLC) accounting for 80% of all cases. To date, platinum-based doublet …

A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer.

H Shi, J Guo, C Li, Z Wang - Drug Design, Development and …, 2015 - europepmc.org
Lung cancer remains the leading common cause of cancer-related death, with non-small-
cell lung cancer (NSCLC) accounting for 80% of all cases. To date, platinum-based doublet …

A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer

H Shi, J Guo, C Li, Z Wang - Drug Design, Development and …, 2015 - dovepress.com
Lung cancer remains the leading common cause of cancer-related death, with non-small-
cell lung cancer (NSCLC) accounting for 80% of all cases. To date, platinum-based doublet …

A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer

H Shi, J Guo, C Li, Z Wang - Drug Design, Development and Therapy, 2015 - go.gale.com
Lung cancer remains the leading common cause of cancer-related death, with non-small-
cell lung cancer (NSCLC) accounting for 80% of all cases. To date, platinum-based doublet …
[PDF] psu.edu

[PDF][PDF] A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer

H Shi - Drug Design, Development and Therapy, 2015 - Citeseer
Lung cancer remains the leading common cause of cancer-related death, with non-small-
cell lung cancer (NSCLC) accounting for 80% of all cases. To date, platinum-based doublet …

A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer

H Shi, J Guo, C Li, Z Wang - Drug design, development …, 2015 - pubmed.ncbi.nlm.nih.gov
Lung cancer remains the leading common cause of cancer-related death, with non-small-
cell lung cancer (NSCLC) accounting for 80% of all cases. To date, platinum-based doublet …